Login / Signup
Thomas Klein
ORCID
Publication Activity (10 Years)
Years Active: 2015-2021
Publications (10 Years): 4
Top Topics
Diabetic Nephropathy
Phase Iii
Amino Acid
Top Venues
ChemMedChem
Diabetes, obesity & metabolism
Mediators of inflammation
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Herbert Nar
,
Gisela Schnapp
,
Oliver T Hucke
,
Timothy Colin Hardman
,
Thomas Klein
Action of Dipeptidyl Peptidase-4 Inhibitors on SARS-CoV-2 Main Protease.
ChemMedChem
16 (9) (2021)
Thomas Klein
,
Harald Tammen
,
Michael Mark
,
Elisa Benetti
,
Denis Delić
,
Cornelia Schepers
,
Maximilian von Eynatten
Urinary dipeptidyl peptidase-4 protein is increased by linagliptin and is a potential predictive marker of urine albumin-to-creatinine ratio reduction in patients with type 2 diabetes.
Diabetes, obesity & metabolism
23 (8) (2021)
Gisela Schnapp
,
Yvette Hoevels
,
Remko A Bakker
,
Patrick Schreiner
,
Thomas Klein
,
Herbert Nar
A Single Second Shell Amino Acid Determines Affinity and Kinetics of Linagliptin Binding to Type 4 Dipeptidyl Peptidase and Fibroblast Activation Protein.
ChemMedChem
16 (4) (2020)
Thomas Klein
,
Günther Klaus
,
Martin Kömhoff
Prostacyclin synthase: upregulation during renal development and in glomerular disease as well as its constitutive expression in cultured human mesangial cells.
Mediators of inflammation
2015 (2015)